IPAC2018 - List of Keywords (medical-accelerators)

Paper	Title	Other Keywords	Page
MOPML069	Enhancing Hadron Therapy through OMA	proton, FEL, simulation, hadron	568
	C.P. Welsch The University of Liverpool, Liverpool, United Kingdom C.P. Welsch Cockcroft Institute, Warrington, Cheshire, United Kingdom
	Funding: This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie SkłodowskaCurie grant agreement No 675265. Continued research into the optimization of medical accelerators is urgently required to assure the best possible cancer care for patients and this is one of the central aims of the OMA project which received 4 M€ of funding from the European Commission. A consortium of universities, research and clinical facilities, as well as partners from industry carry out an interdisciplinary R&D program across three closely interlinked scientific work packages. These address the development of novel beam imaging and diagnostics systems, studies into treatment optimization including innovative schemes for beam delivery and enhanced biological and physical models in Monte Carlo codes, as well as R&D into clinical facility design and optimization to ensure optimum patient treatment along with maximum efficiency. Selected research highlights from across these work packages will be presented and the impact on hadron therapy facilities around the world discussed.
DOI •	reference for this paper ※ https://doi.org/10.18429/JACoW-IPAC2018-MOPML069
Export •	reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)

THPAL042	Injection Locked 1497 MHz Magnetron	injection, superconducting-cavity, site, cavity	3736
	M.L. Neubauer, A. Dudas, S.A. Kahn Muons, Inc, Illinois, USA R.A. Rimmer, H. Wang JLab, Newport News, Virginia, USA
	A novel injection-locked 1497 MHz 13 kW AM magnetron design is presented. The anode design to minimized eddy currents due to the changing magnetic field is presented. Thermal calculations of two design options are also presented. An extra degree of freedom in the anode construction is made possible by the fact that the magnetron is injection locked. This fact presents some additional design details that can be utilized in the cooling network for the magnetron anode.
DOI •	reference for this paper ※ https://doi.org/10.18429/JACoW-IPAC2018-THPAL042
Export •	reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)

Paper

Title

Other Keywords

Page

MOPML069

Enhancing Hadron Therapy through OMA

proton, FEL, simulation, hadron

568

C.P. Welsch
The University of Liverpool, Liverpool, United Kingdom
C.P. Welsch
Cockcroft Institute, Warrington, Cheshire, United Kingdom

Funding: This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie SkłodowskaCurie grant agreement No 675265.
Continued research into the optimization of medical accelerators is urgently required to assure the best possible cancer care for patients and this is one of the central aims of the OMA project which received 4 M€ of funding from the European Commission. A consortium of universities, research and clinical facilities, as well as partners from industry carry out an interdisciplinary R&D program across three closely interlinked scientific work packages. These address the development of novel beam imaging and diagnostics systems, studies into treatment optimization including innovative schemes for beam delivery and enhanced biological and physical models in Monte Carlo codes, as well as R&D into clinical facility design and optimization to ensure optimum patient treatment along with maximum efficiency. Selected research highlights from across these work packages will be presented and the impact on hadron therapy facilities around the world discussed.

DOI •

reference for this paper ※ https://doi.org/10.18429/JACoW-IPAC2018-MOPML069

Export •

reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)

THPAL042

Injection Locked 1497 MHz Magnetron

injection, superconducting-cavity, site, cavity

3736

M.L. Neubauer, A. Dudas, S.A. Kahn
Muons, Inc, Illinois, USA
R.A. Rimmer, H. Wang
JLab, Newport News, Virginia, USA

A novel injection-locked 1497 MHz 13 kW AM magnetron design is presented. The anode design to minimized eddy currents due to the changing magnetic field is presented. Thermal calculations of two design options are also presented. An extra degree of freedom in the anode construction is made possible by the fact that the magnetron is injection locked. This fact presents some additional design details that can be utilized in the cooling network for the magnetron anode.

DOI •

reference for this paper ※ https://doi.org/10.18429/JACoW-IPAC2018-THPAL042

Export •

reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)